메뉴 건너뛰기




Volumn 13, Issue 3, 2012, Pages 9-18

Innovate while derisking drug development - Yes we can!

Author keywords

[No Author keywords available]

Indexed keywords

AUTOMATION; CHEMICAL STRUCTURE; CLINICAL DECISION MAKING; DRUG COST; DRUG DEVELOPMENT; DRUG INDUSTRY; DRUG SAFETY; DRUG TOXICITY; GENOMICS; HEALTH INSURANCE; HIGH THROUGHPUT SCREENING; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MOLECULARLY TARGETED THERAPY; NONHUMAN; OUTCOME ASSESSMENT; PHARMACOLOGY; PHENOTYPE; PHYSIOLOGY; POLYPHARMACY; PROBABILITY; PRODUCTIVITY; PROTEOMICS; REVIEW; RISK REDUCTION; SEMICONDUCTOR; SIMULATION; STANDARDIZATION;

EID: 84864744932     PISSN: 14694344     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (4)

References (3)
  • 1
    • 28044452193 scopus 로고    scopus 로고
    • Therapeutic switching: A new strategic approach to enhance R&D
    • Cavalla, D. Therapeutic switching: a new strategic approach to enhance R&D. IDrugs 8, 914-918 (2005).
    • (2005) IDrugs , vol.8 , pp. 914-918
    • Cavalla, D.1
  • 3
    • 84864775143 scopus 로고    scopus 로고
    • Life cycle management of ageing pharmaceutical assets
    • July/August
    • Manso, PJ and Sokol, AL (2007). Life cycle management of ageing pharmaceutical assets. Pharma Law Insight July/August, 16-19.
    • (2007) Pharma Law Insight , pp. 16-19
    • Manso, P.J.1    Sokol, A.L.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.